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Abstract
Reductions in greenhouse gas (GHG) emissions can bring ancillary benefits of improved air quality
and reduced premature mortality, in addition to slowing climate change. Here we study the
co-benefits of global and domestic GHGmitigation on US air quality and human health in 2050 at
fine resolution using dynamical downscaling of meteorology and air quality from global simulations
to the continental US, and quantify for the first time the co-benefits from foreign GHGmitigation.
Relative to the reference scenario from which Representative Concentration Pathway 4.5 (RCP4.5)
was created, global GHG reductions in RCP4.5 avoid 16 000 PM2.5-related all-cause deaths yr
−1 (90%
confidence interval, 11 700–20 300), and 8000 (3600–12 400) O3-related respiratory deaths yr
−1 in the
US in 2050. Foreign GHGmitigation avoids 15% and 62% of PM2.5-and O3-related total avoided
deaths, highlighting the importance of foreign mitigation for US health. GHGmitigation in the US
residential sector brings the largest co-benefits for PM2.5-related deaths (21% of total domestic
co-benefits), and industry for O3 (17%). Monetized benefits for avoided deaths from ozone and
PM2.5 are $137 ($87–$187) per ton CO2 at high valuation and $45 ($29–62) at low valuation, of
which 31% are from foreign GHG reductions. These benefits likely exceed the marginal cost of GHG
reductions in 2050. The US gains significantly greater air quality and health co-benefits when its GHG
emission reductions are concurrent with reductions in other nations. Similarly, previous studies
estimating co-benefits locally or regionally may greatly underestimate the full co-benefits of
coordinated global actions.
1. Introduction
Exposure to fine particulate matter (PM2.5) and ozone
(O3) is associated with both morbidity (e.g. hospital-
izations, emergency department visits, school absences,
and asthma-related health effects) and premature
human mortality (e.g. deaths from cardiovascular and
respiratory disease and lung cancer), as revealed in
epidemiological studies (US EPA 2009, 2013). Sev-
eral cohort studies have shown evidence for chronic
effects of PM2.5 onmortality (Laden et al 2006, Krewski
et al 2009, Lepeule et al 2012), whereas fewer have
demonstrated the chronic effects of O3 on mortality
(Jerrett et al 2009).
Previous research has quantified future air qual-
ity changes and their effects on human health under
projected emission scenarios, at both the global (West
et al2007, Selin et al2009, Silva et al2016a) and regional
scales (Fann et al 2013, Kim et al 2015, Jiang et al
2015, Sun et al 2015). Climate change can also affect air
© 2017 The Author(s). Published by IOP Publishing Ltd
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quality through several mechanisms, including photo-
chemical reactions, natural emissions, deposition rates,
and air stagnation events (Weaver et al 2009, Jacob and
Winner 2009, Fiore et al 2012, 2015). Related studies
have quantified the effect of global and regional climate
change on air quality and humanhealth (Bell et al 2007,
Tagaris et al 2009, Post et al 2012, Fang et al 2013, Fann
et al 2015). Post et al (2012) used an ensemble of atmo-
spheric models to study the effect of climate change
in 2050 on air quality and human health in the US,
and found significant variability when using different
models.
Many studies have also investigated the co-benefits
of greenhouse gas (GHG) mitigation for air quality
and avoided premature mortality, as actions to reduce
GHG emissions also tend to reduce co-emitted air pol-
lutants (Bell et al 2008, Cifuentes et al 2001, Nemet et al
2010).Whenmonetized, the health co-benefits ofGHG
mitigation were found to range across the literature
from $2–$196/tCO2 (Nemet et al 2010), comparable
to the costs of GHG reductions. Other recent stud-
ies have also analyzed the effects of GHG mitigation
on future air quality and human health co-benefits in
the US (Driscoll et al 2015, Markandya et al 2009,
Thompson et al 2014, Trail et al 2015, Plachinski et al
2014). Thompson et al (2014) studied the co-benefits
of different climate policies in the US on domestic
air quality in 2030, finding that human health bene-
fits due to improved air quality can offset 26%–1050%
of the cost of carbon polices. Other studies also investi-
gate the co-benefits of climate policy on food security,
energy savings, and other health co-benefits of active
transportation (walking, biking) and changes in diet
(Capps et al 2016, Chuwah et al 2015, Friel et al 2009,
Jakob 2006,McCollum et al 2013,Wilkinson et al 2009,
Woodcock et al 2009), but they are not the focus of our
study.
Previous co-benefits studies have been limited by
only considering the co-benefits of regional or local
climate policies on regional air quality and human
health, neglecting (i) the co-benefits of those actions for
other nations or regions, and (ii) the co-benefits gained
domestically from global actions where one country’s
actions are coordinated with reductions internation-
ally. Both PM2.5 and O3 have long enough lifetimes
in the atmosphere to transport intercontinentally, sug-
gesting that emissions fromone source region canaffect
air quality and human health on multiple receptor
regions (Anenberg et al 2009, 2014, Liu et al 2009).
For O3, the health benefits of O3 precursor reductions
may even be greater outside of the source region than
within due to the greater population over several recep-
tor regions (Duncan et al 2008, Anenberg et al 2009,
West et al 2009). PM2.5 has a much shorter lifetime
than O3, but the mortality impacts of intercontinental
transport of PM2.5 are comparable to that of ozone due
to the stronger effects of PM2.5 onmortality (Anenberg
et al 2014). To address these limitations, West et al
(2013), (referred to as WEST2013 hereafter) were the
first to use a global chemical transport model (CTM)
to address the co-benefits of global GHG mitigation
on air quality and human health. WEST2013 were also
the first to estimate co-benefits via two mechanisms:
reduced co-emitted air pollutants, and slowing climate
change and its effects on air quality. They found that
global GHG mitigation could avoid 2.2± 0.8 million
premature deaths in 2100 due to the improved air
quality, accounting for both PM2.5 and O3 mortality.
The co-benefits from the first mechanism of reduced
co-emitted air pollutants are much greater than those
from the second mechanism of slowing climate change
and its effect on air quality. The monetized co-
benefits for health were estimated at $50–$380/tCO2,
globally averaged, higher than previous estimates
(Nemet et al 2010).
WEST2013 applied a global CTM (horizontally
2◦ × 2.5◦) to study the co-benefits. We increased the
horizontal resolution using a limited areamodel frame-
work to further investigate the co-benefits for US air
quality in 2050 at much finer resolution (Zhang et al
2016).Hereweuse the simulationsperformedbyZhang
et al (2016) and focus on quantifying the co-benefits
of global GHG reductions for avoided air pollution-
related mortality in the continental US in 2050. We
study the total co-benefits through the two mecha-
nisms, following WEST2013 and Zhang et al (2016),
and separate the co-benefits of GHG mitigation in the
US versus the contributions from foreign countries.
By embedding this study within the previous global
study of WEST2013, we are the first to investigate
the co-benefits of foreign GHG mitigation for US air
quality and human health. Previous studies have also
investigated the effects of air pollution from specific
emission sectors on premature mortality, both globally
(Lelieveld et al 2015, Morita et al 2014, Yim et al 2015,
Silva et al 2016b) and regionally (Caiazzo et al 2013,
Fann et al 2012, 2013). Here we conduct three new sen-
sitivity simulations to quantify the air quality andhealth
co-benefits of GHG reductions in three US emission
sectors: industry, residential and energy.
2. Methods
2.1. Air quality changes in theUS in 2050 at fine scale
Air quality changes in the US under different GHG
scenarios centered on 2050 were downscaled from
WEST2013 by Zhang et al (2016). Meteorological
fields from the NOAA Geophysical Fluid Dynamics
Laboratory (GFDL) atmospheric model AM3 (Donner
et al 2011, Naik et al 2013), used by WEST2013, was
first downscaled to the regional scale over the continen-
tal US domain to a 36 km horizontal resolution using
the Weather Research Forecast model (WRF, v3.4.1,
Skamarock and Klemp 2008). The WRF configuration
applies spectral nudging to maintain the large-scale
atmospheric circulation resolved by global model
(Otte et al 2012, Bowden et al 2012, 2013). Further
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Table 1. Simulations used for health impact assessment in this study, conducted by Zhang et al (2016), and the three additional sector
simulations for this study. Boundary conditions are from the MOZART-4 (MZ4) simulations of WEST2013. Global methane (CH4)
background concentrations are fixed in CMAQ, consistent with the RCPs andWEST2013. All the simulations are run for three consecutive
years, with four months spin-up.
Years Scenario Emissions Meteorology BCs CH4
2000 S 2000 2000 2000 MZ4 2000 1766 ppbv
S REF REF RCP8.5 MZ4 REF 2267 ppbv
S RCP45 RCP4.5 RCP4.5 MZ4 RCP4.5 1833 ppbv
S Emis RCP4.5 RCP8.5 MZ4 e45m85 1833 ppbv
S Dom aRCP4.5 for US RCP8.5 MZ4 REF 2267 ppbv
2050 S indUS bRCP4.5 for US industry RCP8.5 MZ4 REF 2267 ppbv
S resUS bRCP4.5 for US residential RCP8.5 MZ4 REF 2267 ppbv
S eneUS bRCP4.5 for US energy RCP8.5 MZ4 REF 2267 ppbv
a Apply emissions from RCP4.5 in US and from REF in the parts of Canada and Mexico within the domain.
b Only one sector of emissions from RCP4.5 (e.g. industry, residential and energy) are used, and emissions in other sectors over the US are
from REF, as are emissions over Canada and Mexico in the domain.
information on theWRF configuration can be found in
Zhang et al (2016). GFDL-AM3 was downscaled using
WRF for two periods, a historical period (2000–2003;
here considered 2000), and a future period (2049–
2052; here considered 2050) for the Representative
Concentration Pathway 4.5 (RCP4.5) and RCP8.5 sce-
narios with one year of spin-up. Global anthropogenic
emissions from RCP4.5 and its reference scenario
(REF) were directly processed to the regional scale
using the Sparse Matrix Operator Kernel Emissions
(SMOKE, v3.5,Houyoux et al 2000) program.Dynam-
ical chemical boundary conditions were acquired from
the global CTM outputs of WEST2013. The Com-
munity Multiscale Air Quality model (CMAQ, v5.0.1,
Byun and Schere 2006), with the CB05 chemical mech-
anism with updated toluene reactions and the latest
aerosol module (AE6), was used to simulate air pollu-
tant concentrations (i.e. PM2.5 and O3) in 2000 and
2050. Most of the CMAQ simulations used in this
study (table 1) were completed by Zhang et al (2016),
but three new sensitivity simulations are performed
here to quantify the co-benefits of GHG mitigation
from domestic emission sectors in the US. The CMAQ
simulations fromZhang et al (2016) and the three addi-
tional sensitivity simulations are run for 40 consecutive
months, with the first four months as spin-up, and the
results are presented as three-year averages.
The total co-benefits from global GHG mitiga-
tion are obtained by comparing scenarios S RCP45
and S REF (table 1). As discussed by WEST2013 and
Zhang et al (2016), RCP4.5 was developed based upon
REF, which is a self-consistent representation of future
energy and land use development, with regionally spe-
cific air pollutants emissions, developed consistently
with the assumed future development to 2100 but
without considering climate policy (Smith et al 2011).
Relative to REF, RCP4.5 is created by applying a global
carbon policy spanning all world regions and emis-
sion sectors (Thomson et al 2011); the only difference
between these two scenarios is therefore the carbonpol-
icy. These self-consistent scenarios therefore uniquely
isolate the effects of GHGmitigation (RCP8.5 is used as
a proxy for REF meteorology, since no climate model
simulated REF). The total co-benefits from global
GHG mitigation are obtained by comparing scenarios
S RCP45 and S REF (table 1). As discussed by Zhang
et al (2016), the sensitivity runS Emis applies emissions
from RCP4.5 and meteorology from RCP8.5. To sep-
arate the total co-benefits from the two mechanisms,
we use S Emis minus S REF to give the co-benefits
fromco-emitted air pollutant reductions, and S RCP45
minus S Emis for the co-benefits from slowing climate
change.The sensitivity simulationS DomappliesGHG
mitigation from the RCP4.5 scenario in the US only, so
the co-benefits of domestic GHG mitigation are esti-
mated as S Domminus S REF, and foreign co-benefits
as S RCP45 minus S Dom.
In addition, we simulate three more scenarios
to identify the co-benefits from actions to reduce
GHG emissions in individual sectors domestically. We
choose to simulate reductions in the industry (S indUS,
manufacturing industries, industrial process emissions
other than solvents, construction, mining, and agricul-
turalmachinery), residential and commercial buildings
(S resUS, primarly from cooking, heating and hot
water), and energy sectors (S eneUS, from electric
power generation and energy extraction and transfor-
mation), because air pollutant emission reductions in
RCP4.5 in 2050 are greatest from these sectors in the
US. Although ground transportation is the largest con-
tributor for most air pollutants in the US in 2000 and
2050, we did not select transportation as little air pol-
lutants reductions are seen from this sector in 2050.
The air pollutant emission reductions from the three
sectors selected here account for more than 98% of
the total SO2 and NOx reductions in RCP4.5 relative
to REF in the US in 2050, 80% of the CO reductions,
and more than 50% of the EC and OC reductions.
However, these three sectors only account for 11%
of the total non-methane volatile organic compound
(NMVOC) decreases (supplementary table S1 available
at stacks.iop.org/ERL/12/114033/mmedia).
2.2. Human health analysis
We use the environmental Benefits Mapping and
Analysis Program–Community Edition (BenMAP-CE,
v1.08) (US EPA 2014) to calculate the avoided human
mortality associated with future surface air quality
3
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Figure 1. Total air quality co-benefits (S RCP45-S REF) in 2050 for (a) annual average PM2.5, and (b) 6 month ozone-season average
of 1 hr daily maximum of O3. Results are presented as three-year averages. Negative values (blue) indicate air quality improvements.
changes for both PM2.5 and O3. BenMAP-CE calcu-
lates the relationship between air pollution and certain
health effects, using a health impact function (HIF)
from epidemiological studies. The HIFs for PM2.5 and
O3 used in this study are based on a log-linear rela-
tionship between relative risk (RR) and air pollutant
concentrations defined by epidemiology studies (Jer-
rett et al 2009, Krewski et al 2009), which are also used
byWEST2013. RR is used to calculate attributable frac-
tion (AF), the fractionof thediseaseburdenattributable
to the risk factor, which is defined as:
AF = RR − 1
RR
= 1 − exp−𝛽Δ𝑥 (1)
where 𝛽 is the concentration–response factor (CRF; i.e.
the estimated slope of the log-linear relation between
concentration and mortality) and Δx is the change in
air pollutant concentration between two scenarios. AF
is multiplied by the baseline mortality rate (y0), and
the exposed population (Pop) to yield an estimate of
excess deaths attributable to changes in air pollution
(ΔMort):
ΔMort = 𝑦0 × (1 − exp−𝛽Δ𝑥) × Pop. (2)
We present results for all-cause mortality from the
PM2.5 changes, rather than cardiopulmonary disease
(CPD) and lung cancer (LC), as all-cause mortality is
the most comprehensive estimate of PM-related mor-
tality appropriate for theUS.However,we also estimate
thePM-relatedmortality fromCPDandLC tocompare
with the results of WEST2013. We also quantify the
premature mortality from respiratory disease (RESP)
associated withO3 changes. The 90% confidence inter-
vals (CI) presented in this study are calculated using a
full Monte Carlo analysis inside BenMAP-CE consid-
ering only uncertainty in the HIF.
BenMAP-CE uses county-level baseline mortal-
ity rates for the present day and projected to 2050
at five-year intervals, including RESP for O3, and
all-cause, CPD, and LC for PM2.5 (RTI Interna-
tional 2015). Overall, the projected baseline mortality
rates within BenMAP-CE decrease from 2005–2050.
However, the baseline mortality rates used by
WEST2013 are projected to increase in 2050 in the US,
derived from the International Futures (IFs, version
6.54, Hughes et al 2011) under the UNEPGEO Base
Case scenario. For population, BenMAP-CE includes
the future population projection at county level in
the US until 2040 only (totalling 403 million, Woods
and Poole 2012), but our study is focused on 2050
(the RCP4.5 projected total population is 384 mil-
lion in 2050, Clarke et al 2007). To be consistent
with WEST2013, we run BenMAP-CE with baseline
mortality rates in 2005 and the population projection
in 2040 (aged 30 and above), and then post-process
the BenMAP-CE outputs by multiplying adjustment
ratios to match the US population and US average
baseline rates of WEST2013 (supplementary table S2).
By doing so, we assume that future baseline mortal-
ity rates increase at a uniform national ratio in each
county without age, gender or ethnic variations, and
that the spatial distribution of population in 2050
of RCP4.5 is the same as that in 2040 projected by
Woods and Poole (2012).
3. Results
The total US PM2.5 concentration co-benefits in 2050
from global GHGmitigation (−0.47 𝜇gm−3 for three-
year US annual average) are greatest in the East and
California (CA), and less in the West (figure 1(a)).
For O3, we calculate the three-year average of the
6 month ozone-season average of 1 hr daily maxi-
mum O3, to be consistent with Jerrett et al (2009),
and the total US O3 co-benefits in 2050 from global
GHGmitigation (−2.96 ppbv for three-year US ozone-
season average) are fairly uniform over the US domain
(figure 1(b)), slightly higher over the Western US than
the East. The population-weighted average (for the
2050 exposed population age 30 and older) for the
PM2.5 co-benefit (−0.84 𝜇gm−3 for US average) is
almost twice the simple average (table 2), as PM2.5
has a short lifetime and is therefore distributed locally
to regionally (Punger and West 2013). Population
4
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Table 2. Co-benefits for air quality changes in the continental US in 2050 from global, domestic and sectoral GHGmitigation. For PM2.5
(𝜇gm−3) we use the three-year average, and for O3 (ppbv), we calculate the 6 month ozone season of 1 hr daily maximum, and then average
over three years. Co-benefits are estimated using RCP4.5 minus REF. Negative values indicate air quality improvements.
PM2.5 O3
Simple average Pop-weighted average Simple average Pop-weighted average
Emission −0.45 −0.82 −2.75 −2.89
Climate −0.02 −0.02 −0.21 −0.13
Total −0.47 −0.84 −2.96 −3.02
Domestic −0.35 −0.71 −0.80 −1.07
Foreign −0.12 −0.13 −2.16 −1.95
Industry −0.057 −0.11 −0.22 −0.20
Domestic Residential −0.058 −0.15 −0.11 −0.058
Energy −0.046 −0.089 −0.13 −0.14
Table 3. Estimated total co-benefits for avoided premature mortality in 2050 from PM2.5-related all-cause mortality and O3-related
respiratory mortality (deaths yr−1). The values in parenthesis are 90% confidence intervals (CI). Co-benefits are estimated using RCP4.5
minus REF. Positive values indicate fewer deaths.
PM2.5 O3
Emission 15 800 (11 500–20 000) 7600 (3400–11 700)
Climate 300 (200–400) 500 (200–700)
Total 16 000 (11 700–20 300) 8000 (3600–12 400)
Domestic 13 600 (9900–17 300) 3000 (1300–4700)
Foreign 2400 (1800–3100) 5000 (2200–7800)
Industry 2100 (1500–2700) 500 (200–800)
Domestic Residential 2800 (2000–3600) 200 (100–300)
Energy 1700 (1200–2200) 300 (100–500)
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16000 (11700-20300) 8000 (3600-12400)
Figure 2.Total co-benefits (S RCP45-S REF) for avoided premature mortality (deaths yr−1) in theUS in 2050, for (a) PM2.5 (all-cause
mortality), and (b) O3 (respiratory mortality). Total avoided deaths and 90% confidence intervals are shown at the top of each panel.
Positive values indicate fewer deaths.
weighting has less of an impact on the O3 estimates
as the longer lifetime of O3 produces a more uniform
spatial distribution.
For the human health benefits from the global
GHG mitigation, our results show that 16 000
(90% CI: 11 700–20 300) premature deaths will be
avoided annually in the US in 2050 due to PM2.5
decreases (table 3). The states with the most avoided
deaths are CA (2500 deaths, CI: 1800–3200), New
York (NY, 1300 deaths, CI: 1000–1700) and Texas
(TX, 1200 deaths, CI: 800–1500) (supplementary fig-
ure S1 and table S4), with each state having large
population and large PM2.5 decreases (figure 1, sup-
plementary table S4). For O3, the total avoided deaths
in the US are 8000 (CI: 3600–12 400), 50% fewer than
PM2.5, and also highest in CA (1400, CI: 600–2200),
NY (500, CI: 200–800) and TX (500, CI: 200–700).
The spatial patterns of both PM2.5 and O3 related
avoided premature mortality are shown in figure 2.
We further quantify the human health co-benefits
from global GHG mitigation by calculating the
avoided mortality per capita (MPC, the avoided
deaths per million people age 30 and older) in 2050,
for both PM2.5 and O3 (supplementary figure S2, table
S4). TheMPC forPM2.5 ismuchhigher in theEast than
in the West (except for CA), with much greater vari-
ation than for O3, consistent with the finding that the
total concentration co-benefits vary locally to region-
ally for PM2.5, and are more spatially uniform for O3
(figure 1). Relative to the present, air quality improves
and premature mortality decreases in the future under
REF, due to the large projected emission reductions
of conventional air pollutants (Silva et al 2016a, Smith
et al 2011, West et al 2013, Zhang et al 2016).
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Figure 3. Comparisons between this study (red) and WEST2013 (blue) of the avoided human mortality in the US (1000 deaths yr−1)
from air quality changes in 2050 compared with 2000, for (a) REF scenario, (b) RCP4.5 scenario, and (c) the total co-benefits in 2050.
The red lines represent the 90% confidence intervals (CI) for this study, and blue lines are 95% CI for WEST2013. RESP indicates
mortality from O3-related respiratory deaths, CPD for PM2.5-related cardiopulmonary deaths, and LC for PM2.5-related lung cancer.
We then compare the health results in this study
with WEST2013 for the avoided deaths from 2000
to 2050 under the REF (S REF-S 2000) and RCP4.5
(S RCP45-S 2000) scenarios, and the total co-benefits
in 2050 (S RCP45-S REF). Zhang et al (2016) con-
cluded that future PM2.5 changes are greater using
the regional CMAQ model simulations than those in
WEST2013 for both REF (S REF-S 2000) and RCP4.5
(S RCP45-S 2000) scenarios, while the future O3
changes in 2050 were comparable between CMAQ and
WEST2013. When quantifying human health impacts,
figure 3 shows that the avoided premature mortality
for PM2.5 for both REF and RCP4.5 relative to S 2000
are higher in this study than WEST2013, especially for
CPD, which is consistent with the greater reductions in
PM2.5 predicted here. The avoided premature mortal-
ity for O3 for both REF and RCP4.5 relative to S 2000
are comparable between this study and WEST2013.
The total co-benefits for the population-weighted air
quality changes are higher for WEST2013 (4.56 ppbv
for O3 and 1.30 𝜇gm
−3 for PM2.5, figure S26 and
S29 in WEST2013) than our estimations using the
regional model (3.02 ppbv for O3 and 0.84 𝜇gm
−3 for
PM2.5, table 3), but the estimated total co-benefits for
avoided mortality are similar (figure 3 in this paper).
The fact that the total co-benefits for avoided deaths
are comparable between this study and WEST2013,
even though air quality changes are different, may be
in part due to the use of county-level baseline mor-
tality rates here vs the national average of WEST2013.
Note that the total avoided deaths from the sum of
CPD (24 300 deaths yr−1) and LC (3200 deaths yr−1)
is larger than the co-benefits calculated for all-cause
mortality, as the RRs for CPD (1.13, 95%CI:1.1–
1.16) and LC (1.14, 95%CI:1.06–1.23) are greater than
that for all-cause mortality (1.06, 95%CI:1.04–1.08)
(Krewski et al 2009).
We then separate the total co-benefits into the
two mechanisms. The co-benefit of reductions in
co-emitted air pollutants (the ‘emission co-benefit’)
accounts for 98% of the total co-benefits (three-year
population-weighted average of−0.84𝜇g m−3, table 2)
for PM2.5, and 96%of the total (three-year population-
weighted average of−3.02 ppb) for O3, consistent with
WEST2013 and Zhang et al (2016). When calculat-
ing the co-benefits for human health, the emission
co-benefit also dominates the total co-benefits, with
15 800 (CI: 11 500–20 000) avoided deaths for PM2.5
(98% of the total), and 7600 (CI: 3400–11 700) for O3
(94% of the total) (table 3, figure 4). The difference
between the total co-benefit and the emission co-
benefit is accounted for by the effect of slowing climate
change and its effects on air quality (the ‘climate co-
benefit’). Notice that the climate co-benefit is negative
in some locations, e.g. the Northern states for PM2.5,
and Southeast for O3, where slowing climate change
can cause concentrations and air pollution-related
deaths to decrease as a result of more precipitation
and lower temperature (see figure 1 in Zhang et al
2016). For the climate co-benefits, we only simulate
three years, which may reflect climate variability in
addition to climate change (Deser et al 2012). How-
ever, sincewe estimate that the emission co-benefits are
much greater than the climate co-benefits, we conclude
that more years of simulations would not affect this
conclusion.
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Figure 4. The emission co-benefits (a), (b) and climate co-benefits (c), (d) for avoided human mortality in 2050 (deaths yr−1) from
PM2.5 (a), (c) and O3 (b), (d). White in panels (c) and (d) indicates increased mortality attributed to slowing climate change, from
increases in air pollutant concentrations. Total avoided deaths and 90% confidence intervals are shown at the top of each panel.
Positive values indicate fewer deaths.
GHG reductions from foreign countries account
for 2400 avoided deaths (CI: 1800–3100) for PM2.5-
related all-cause mortality, and 5000 (CI: 2200–7800)
deaths for O3-related RESP, which are 15% and
62% of the total deaths for PM2.5 and O3 (table 3).
Foreign GHG mitigation likewise contributes 15%
(−0.13 𝜇gm−3 for the three-year US population-
weighted average) of the total air quality co-benefits for
PM2.5, and 65% (−1.95 ppbv) of the total co-benefits
for O3, emphasizing that PM2.5 is more influenced by
emission reductions inUS, whileO3 ismore influenced
by the global methane reductions and intercontinental
air pollutant transport (Zhang et al 2016). Foreign co-
benefits for both PM2.5- and O3-related mortality are
centred in urban areas (figure 5), where population
density is high, even though foreign GHG mitiga-
tion reduces surface O3 pretty uniformly in the US
(see supplementary figure S3). The contributions from
domestic GHG mitigation on population-weighted
average PM2.5 (85% of the total) and O3 (35%) are
higher than those for the simple average (74% for
PM2.5 and 27% for O3 in table 2), as air quality
improvements from domestic GHG mitigation occur
in densely-populated areas. CA has the largest human
health benefits from foreign GHG mitigation, with
400 deaths (CI: 300–500) avoided from PM2.5-related
all-cause mortality, and 800 deaths (CI: 400–1300)
avoided from O3. We have calculated total, domes-
tic, and foreign mortality co-benefits for each state
(see supplementary tables S4–S6). In quantifying the
domestic co-benefits, we neglect the effect of US GHG
mitigation on global climate change, and assume that
global and regional climate will be controlled by for-
eign GHG emissions, which introduces a small error
into our results. We also attribute the global methane
concentration change to the effect of foreign GHG
reductions, as US emissions are relatively small (6%–
10% of global emissions).
Among emission sectors, the residential sector
has the largest co-benefits for PM2.5-related human
health, avoiding2800deaths (CI: 2000–3600), account-
ing for 21% of the total domestic co-benefits for
PM2.5, followed by industry (2100, CI: 1500–2700)
and energy (1700, CI: 1300–2200). Residential also
has the largest change in the population-weighted
annual average PM2.5 (−0.15 𝜇gm−3), even though
its simple annual average change is comparable to
that from the industry sector, demonstrating that res-
idential emissions have a greater influence near where
people live. GHG mitigation from industry has the
largest effect on O3-related human health, avoiding
500 deaths (200–800) or 17% of the total domestic
co-benefits for O3, followed by energy (300, CI:100–
500), and residential (200, CI:100–300). The total air
quality co-benefits for O3 are also highest in industry
(population-weighted average of−0.20 ppb and simple
average of −0.22 ppbv). These three sectors together
account for 50% of the total avoided PM2.5-related
deaths from domestic GHG reductions and 33% of
the total avoided O3-related deaths, even though the
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Figure 5. Domestic (a), (b) and foreign co-benefits (c), (d) for avoided all-cause mortality from PM2.5 (a), (c) and respiratory disease
from O3 (b), (d) in the US in 2050. Total avoided deaths and 90% confidence intervals are shown at the top of each panel. Positive
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sectorsaccount fora larger fractionof emissionsofmost
pollutants, possibly reflecting the smaller NMVOC
emissions decreases from these sectors in RCP4.5.
These findings of greater avoided deaths for residential
GHG reductions suggest that residential sources might
be targeted in policy efforts. Future research should
attempt to evaluate air quality and health co-benefits
for more specific GHGmitigation measures, including
for other sources such as transportation, so that these
co-benefits can be evaluated alongside the cost of GHG
mitigation.
The total co-benefits of avoided premature
mortality aremonetized using high ($9.81million) and
low ($3.25 million) values of a statistical life (VSLs)
for the US in 2050, as estimated by WEST2013 (in
2005 US$) based on projected income growth. Adding
avoided mortality from O3 and PM2.5, and dividing
monetized benefits by US CO2 reductions in 2050, we
estimate monetized co-benefits in 2050 of $137 ($87–
$187) per ton CO2 reduced at a high VSL, and $45
($29–$62) per ton CO2 reduced at a low VSL, very
similar to the 2050 estimates of WEST2013 for the US.
As for WEST2013, these monetized estimates do not
account for avoided deaths outside of the US. These
benefits at high VSL exceed the full range of GHG
marginal abatement cost estimates from 13 energy-
economic models (West et al 2013), and at low VSL are
greater than themedian cost. Of these total co-benefits,
foreign GHG reductions are responsible for monetized
benefits of $42 ($23–$62) per tonCO2 at highVSL, and
$14 ($8–$21) at low VSL, which is 31% of the total
monetized benefits.
4. Conclusions
We quantify the co-benefits of global GHG mitiga-
tion under the RCP4.5 scenario on US air quality and
human health in 2050 using dynamical downscaling.
We find that 16 000 (11 700–20 300) deaths yr−1 will
be avoided for PM2.5-related all-cause mortality, and
8000 (3600–12 400) deaths yr−1 will be avoided for
O3-related respiratory mortality. When separating the
total co-benefits into two mechanisms, the emission
co-benefits have a larger impact than the climate co-
benefits for both PM2.5 and O3, accounting for 98%
and 94%of the total avoided deaths. ForeignGHGmit-
igation contributes 15% of the total PM2.5-related and
62% of the total O3-related deaths. Among the three
domestic emission sectors with the greatest reductions
in air pollutants underRCP4.5, residential has thehigh-
est co-benefits for PM2.5-related mortality, leading to
a reduction of 2800 deaths, and industry has the high-
est co-benefits for O3, avoiding 500 deaths in the US.
Monetized co-benefits of the GHG mitigation,
accounting for avoided deaths from reductions in both
PM2.5 and O3, are $137 ($87–$187) per ton CO2 at a
high VSL and $45 ($29–$62) at a low VSL. Of these co-
benefits, 31% come from the influence of foreign GHG
reductions. These benefits likely exceed the marginal
costs of GHG reductions in 2050.
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Significant uncertainties exist in our results. For
PM2.5, we compare the uncertainty for the future con-
centration change under RCP4.5 of −2.92%± 2.3%
𝜇gm−3 (−2.79%± 22.0% 𝜇gm−3 for the PM25 esti-
mated as a sum of species) based on the spread of
ACCMIP models (Silva et al 2013, Zhang et al 2016),
and the uncertainty for the CRF is 0.0058%± 32.8%.
For O3, the uncertainty for the future concentration
change under RCP4.5 is −5.87%± 48.8% ppbv, and
theuncertainty for theCRFis0.0039%± 69.2%.There-
fore, the uncertainty in the CRF likely contributes
more to the overall uncertainty than the uncertainty in
modeled concentration changes, although, for ozone,
concentration uncertainty is of similar magnitude to
the CRF uncertainty. When quantifying the avoided
deaths from improved air quality, we only account for
adults above 30. Additional uncertainty arises from
downscaling from the global to the regional scale
chemistry model, including the conversion of chem-
ical mechanisms in the models, particularly from the
addition of new inorganic species for primary PM2.5
(Zhang et al 2016). Different components of PM2.5
may have different effects on human health, like black
carbon particles (Li et al 2016, Zanobetti and Schwartz
2009). However, we consider all of the components of
PM2.5 to have equal toxicity. Only a single modelling
system (AM3-WRF-SMOKE-CMAQ) is used in this
study, and as pointed out previously (Post et al 2012,
Silva et al 2013), results may differ among different
models and ensembles of models can better charac-
terize the range of results. Similarly, increasing the
number of years simulated by themodels used here can
reduce uncertainty related to inter-annual variability
(Deser et al 2012). Our conclusions are specific to
the REF and GHG mitigation (RCP4.5) scenarios we
choose, including their simulation of future emission
pathways, which depend on economic drivers and
air pollution control policies, and would differ for
other scenarios. For example, the new shared socio-
economic pathways 4 (SSP4) have different climate
policy assumptions considering economic, institu-
tional and technological limitations (Rao et al 2017),
and different emission reductions for co-emitted air
pollutants in 2050 (supplementary table S3). We only
account for the co-benefits from air quality changes
due to the GHG mitigation, neglecting other impacts
of climate change on health, like heat-waves, elevated
temperatures, and infectious disease (Smith et al 2014).
Despite these uncertainties, both those quantified and
unquantified, our major conclusion that global GHG
mitigation can have significant co-benefits for air qual-
ity and avoided mortality in the US is unlikely to be
altered.
Future studies should estimate co-benefits at both
the global and regional scales with finer-resolution
air quality model simulations. Uncertainties could be
reduced by improving emission estimates for mul-
tiple species, the chemical and aerosol mechanisms
(CB05 and AE6), and using multi-year simulations
and ensemble model experiments (Rao et al 2016).
Future air pollutant reference-case emission trajecto-
ries are also uncertain (e.g. Rao et al 2017), and use
of multiple future scenarios would also be valuable.
Future studies should also evaluate benefits beyond
health, such as for agriculture and energy. Previous
studies have shown that using coarse resolutionmodels
tends to underestimate mortality near urban areas for
PM2.5 (Punger and West 2013, Li et al 2015). Improv-
ing horizontal resolution in future studies can produce
more robust estimates of health benefits, andmay cause
estimates to increase.
Previous studies have estimated co-benefits of
GHG mitigation mainly on local, national, or con-
tinental scales (Bell et al 2008, Cifuentes et al 2001,
Nemet et al 2010). These studies have presumed that
most co-benefits are realized on those scales, and that
the contributions of foreign GHG mitigation to total
co-benefits would be small. Here we show that the
US can gain significantly greater co-benefits for air
quality and human health, especially for ozone, when
coordinating its GHG emission reductions with con-
current reductions in other nations to combat global
climate change. Similar results would also be expected
for foreign countries, whichwill likely also benefit from
GHG mitigation in other countries. Previous stud-
ies, which only estimate co-benefits from regional or
local GHG mitigation may significantly underestimate
the full co-benefits of coordinated global actions to
mitigate climate.
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